Windtree Acquires Early-Stage, Novel Oncology Platform and

WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), today announced that on...

Related Keywords

Israel ,Ukraine ,Taiwan ,Gaza ,Israel General ,Republic Of China ,Taiwan General ,United States ,Russia ,Craig Fraser ,Jeric Curtis ,Exchange Commission ,Windtree Therapeutics Inc ,Varian Biopharmaceuticals Inc ,Company Nasdaq ,Drug Administration ,Varian Biopharmaceuticals ,Seriesb Convertible Preferred Stock ,Preferred Shares ,Chief Executive Officer ,Notes Offering ,Nasdaq Stock ,Current Report ,Windtree Therapeutics ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Nasdaq Wint ,